The study aims included: (1) evaluate change in BMI across time and by age in adults with DS; (2) determine the effect of baseline PET Aβ and tau on BMI change; and (3) evaluate the association between change in BMI and change in memory and dementia symptoms. This evidence concerns the gene MAPT and Dravet syndrome.